Contribution of HMGB1 to Keratinocyte inflammation in Recessive Dystrophic Epidermolysis Bullosa
Bui, K. G.; Chang, Y.-C.; Chiraphapphaiboon, W.; Wang, J.; Ebens, C. L.; Bielinsky, A.-K.; Tolar, J.; Nguyen, H. D.
Show abstract
Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited skin disorder characterized by fragile skin, blistering, and chronic wounds. Keratinocytes, the primary cells in the epidermis, are directly affected by persistent injury in RDEB, contributing to chronic inflammation. High mobility group box 1 (HMGB1) is elevated in the serum of individuals with RDEB. However, its role in keratinocyte inflammation remains unclear. Here, we report an increase in HMGB1 expression in keratinocytes at chronic wound sites compared to matched non-wounded skin from an RDEB individual, suggesting a potential link to local inflammation. Pharmacological inhibition of HMGB1 using inflachromene reduced lipopolysaccharide (LPS)-induced inflammatory responses in a keratinocyte cell line, supporting a role for keratinocyte-specific HMGB1 in inflammation. Surprisingly, deletion of HMGB1 alone or together with its paralogue HMGB2 did not suppress the inflammatory response to LPS. Furthermore, inflachromene still reduced inflammation in these knockout cells. This unexpected discrepancy between genetic deletion and pharmacologic inhibition points to a more complex role for HMGB1 or off-target effects of the compound. These findings suggest that HMGB1 may contribute to inflammation in keratinocytes, but its exact function needs further investigation.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- The ADAM17 sheddase complex regulator iTAP modulates inflammation, epithelial repair, and tumor growth 94%
- ETV2 regulates PARP-1 binding protein to induce ER stress-mediated cell death in tuberin-deficient cells 93%
- Identification of a novel enhancer essential for Satb1 expression in TH2 cells and activated ILC2s. 93%
Similar papers in this journal
Similar papers in this journal
- Persistent oxidative stress and inflammasome activation in CD14 high CD16 - monocytes from COVID-19 patients 93%
- The EGFR/ErbB inhibitor neratinib modifies the neutrophil phosphoproteome and promotes apoptosis and clearance by airway macrophages 93%
- Determining distinct roles of IL-1α through generation of an IL-1α knockout mouse with no defect in IL-1β expression 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.